Hyderabad: BioAsia 2025 to kick off on Feb 25; Telangana to showcase biotech, pharma prowess

Hyderabad: The stage is all set for BioAsia 2025, Asia’s premier life sciences and health tech forum. The two-day event will kick off on February 25 in Hyderabad. The event will bring together global healthcare leaders, policymakers, MSMEs, and startups to discuss advancements in AI-driven healthcare, life sciences innovation, and clinical research.

Prominent speakers at the event include A. Revanth Reddy, Chief Minister of Telangana; Dr. Jeannette Young, Governor of Queensland; Amitabh Kant, G20 Sherpa; and Piyush Goyal, Minister of Industry and Supplies, Government of India.

Industry leaders such as Robert A. Bradway (CEO, Amgen), Prof. Patrick Tan (Executive Director, Genome Institute of Singapore), Dr. Ken Washington (CTO, Medtronic), and Dr. Boris Stoffel (Managing Director, Miltenyi Biotec) will also participate across the sessions.

CEO Conclave to Address Industry Challenges

A key highlight of the event will be the CEO Conclave on February 25, featuring discussions on opportunities and challenges in the Indian and global life sciences sectors. Speakers include:

• Dr. S. Somanath, Former Chairman, ISRO

• Satish Reddy, Chairman, Dr. Reddy’s Laboratories

• Dr. Krishna Ella, Chairman & MD, Bharat Biotech International Ltd

• Dr. Satyanarayana Chava, Founder & CEO, Laurus Labs

• Cesar Concepcion, Chief Commercial Officer, APMA region, Novartis

• Winselow Tucker, President & General Manager, Lilly India

The conclave will explore India’s role in disruptive healthcare innovation, AI adoption in life sciences, and global collaborations.

Telangana’s Role in Global Healthcare Innovation

The event will reinforce Telangana’s position as a key player in medical research, biotechnology, and pharmaceutical development. Minister for Industries and Commerce, Sridhar Babu, highlighted BioAsia’s impact, stating:

“BioAsia 2025 marks the 22nd edition of Asia’s leading life sciences and healthcare forum, bringing together global leaders to discuss AI-driven healthcare transformation, innovations in life sciences, data interoperability, and India’s potential in clinical trials. I am confident this will be the biggest and most impactful BioAsia in history.”

Special Chief Secretary Jayesh Ranjan noted the diverse participation and industry collaborations:

“The diverse lineup of speakers at BioAsia 2025 will further establish it as a premier platform for knowledge exchange and future-shaping discussions. Organizations like Deloitte, BCG, EY-Parthenon, and HealthArk have partnered with BioAsia to curate the program, ensuring meaningful conversations on the future of healthcare and life sciences.”

Spotlight on AI-Driven Healthcare and Research

The event will feature high-impact panel discussions, networking opportunities, and collaborations between global industry leaders and startups. CEO of BioAsia and Director of Telangana Life Sciences, Shakthi Nagappan, emphasized:

“India has immense potential to lead the convergence of life sciences and technology, and Telangana continues to be at the forefront of this transformation. BioAsia 2025 is set to be a landmark edition, with several global leaders participating. We are particularly excited to welcome thought leaders like Dr. S. Somanath, whose expertise in space sciences and engineering brings a fresh perspective to addressing challenges in life sciences.”

With India emerging as a global leader in biotechnology and healthcare, BioAsia 2025 will serve as a key platform for investment, collaboration, and knowledge-sharing.